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ABSTRACT
Purpose: Newly diagnosed HIV infections among men
who have sex with men (MSM) are rising in many
European countries. Surveillance tools must be tailored
to the current state of the epidemic, and include
decentralised prospective monitoring of HIV incidence
and behavioural changes in key populations. In this
scenario, an open prospective cohort study was
assembled—The Lisbon Cohort of MSM—aiming to
dynamically monitor the frequency of disease and its
predictors.
Participants: The Lisbon Cohort of MSM is an
ongoing observational prospective study conducted at
a community-based voluntary HIV counselling and
testing centre in Lisbon, Portugal (CheckpointLX). Men
testing negative for HIV, aged 18 or over and reporting
having had sex with men are invited to follow-up visits
every 6 months. At each evaluation, a face-to-face
interview using a structured questionnaire is
conducted, and HIV and syphilis rapid tests are
performed by trained peer counsellors. From April
2011 to February 2014, 3106 MSM were eligible to the
cohort of whom 923 (29.7%) did not participate. The
remaining 2183 (70.3%) MSM were enrolled and 804
had at least one follow-up evaluation, for a total of 893
person-years of observation.
Future plans: The study findings will be disseminated
in peer-reviewed journals and presented at national and
international conferences. The follow-up of this cohort
of HIV-negative MSM will be a valuable tool for
monitoring HIV incidence in a setting where limited
prospective information existed. Moreover, it will allow
for a deeper analytical approach to the study of
population time trends and individual changes in risk
factors that currently shape the HIV epidemic among
MSM.
INTRODUCTION
Since the beginning of the HIV/AIDS epi-
demic in the early 80s, gay, bisexual and
other men who have sex with men (MSM)
have been a core population affected by the
disease, but also key contributors to the
response to it.1 2 During the past three
decades, signiﬁcant scientiﬁc advances and
societal efforts in the ﬁelds of prevention,
treatment, care and support have renewed
the hope of achieving an AIDS-free gener-
ation. However, in many high-income coun-
tries where a decline in overall HIV
diagnoses have been observed, a concurrent
increase in the number of new cases among
MSM has also been documented.3 In the
European Union/European Economic Area
(EU/EEA) the largest increase in new diag-
noses in the last decade was observed among
young MSM, aged 20–29 years old.4
In Portugal, as in most EU/EEA countries,
the HIV epidemic is concentrated in certain
key populations, such as MSM, people who
inject drugs, prisoners and commercial sex
workers.5 A large internet survey on
Portuguese MSM found a prevalence of self-
reported HIV infection of 10.9% among par-
ticipants with a previous HIV test.6 Although
with different methodology, a previous inter-
view survey found a very similar prevalence
of 10.3% of self-reported HIV infection
among participants ever tested (Gama A,
2013, personal communication).
Portuguese ofﬁcial surveillance data show a
9% annual increase in the number of newly
diagnosed HIV cases among MSM from 2005
to 2012, while cases due to unsafe injection
behaviour and heterosexual intercourse
decreased by 18% and by 2%, respectively, in
the same period.7 In 2013, sex between men
accounted for 42.9% of all HIV cases
reported in men and 30.3% of all cases.7
Hence, there is an urgency to establish
dynamic instruments to monitor HIV
Strengths and limitations of this study
▪ Enables the dynamic monitoring of the frequency
of the disease and its predictors.
▪ Enables the comparison of the findings with
other cohorts.
▪ Limited representativeness of the sample.
▪ Selection and participation bias.
▪ Possible Hawthorne effect.
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incidence and determinants in this population if, in fact,
we want to succeed in the response to HIV among
MSM.1
HIV surveillance must be tailored to the state of the
epidemic in each setting, and this includes the promo-
tion of decentralised surveillance tools that are capable
of capturing HIV trends and behavioural changes in a
more timely and analytical fashion than national surveil-
lance systems, which are necessarily heavier structures
with a resulting limited applicability for behavioural
research.8
Community-based studies of MSM present great chal-
lenges, namely when it comes to deﬁning a sampling
frame,9 due to the clear difﬁculty in establishing the
boundaries of the target population itself because of cul-
tural, anthropological and sociological reasons.
Traditional sampling strategies designed to ensure repre-
sentativeness and external validity, such as simple,
random or cluster sampling, are often not efﬁcient
enough to recruit and follow MSM.8–11 Alternative sam-
pling techniques such as convenience sampling in
community-based facilities devoted to MSM can be sub-
stantially more feasible and improve crucial attributes
for the success of integrated epidemiological surveil-
lance such as simplicity, acceptability of participants and
stability.8–12
The Lisbon Cohort of MSM was assembled as a facility-
based open prospective cohort in a community-based
voluntary HIV counselling and testing service directed at
MSM. The main objectives of the study are: on a ﬁrst
stage, to quantify the frequency of the disease by estimat-
ing the incidence of HIV infection in MSM, and moni-
toring trends in primary (condom use for anal
intercourse (AI)) and secondary prevention (early
detection); and, in a subsequent stage, to identify strat-
egies to improve the provision of HIV testing.
Cohort description
The Lisbon Cohort of MSM is an ongoing observational
prospective study established in April 2011, designed as
an open cohort. Eligible participants are MSM, aged 18
or older, regardless of nationality or residence, who vol-
untarily attend CheckpointLX for HIV testing and coun-
selling, and who have a negative HIV test result at the
time of recruitment.
Setting
The cohort is a joint project of GAT Portugal (GAT)
and the Institute of Public Health of the University of
Porto (ISPUP). GAT is a non-governmental organisation
advocating legal and political changes that can have a
positive effect on the rights and quality of life of those
living with HIV, or those most at risk of acquiring the
infection. One of GAT’s projects has materialised in
CheckpointLX, where the Lisbon Cohort of MSM is
recruited. CheckpointLX is a community-based centre
for anonymous and free rapid HIV testing and counsel-
ling, targeted at MSM, and provided by trained peer
MSM counsellors. ISPUP is an advanced training and
research institution in the Public Health domain. With
respect to the cohort study, CheckpointLX is responsible
for recruitment and data collection, while ISPUP pro-
vides scientiﬁc support, data management and analysis.
Both institutions were involved in the design and imple-
mentation of the cohort protocol, and both have estab-
lished an ofﬁcial partnership to guarantee a shared
commitment to the follow-up of cohort participants, and
to the periodic dissemination and evaluation of research
outputs.
Ethics
The collected data are conﬁdential, and the participants
give their written informed consent prior to inclusion.
Furthermore, in accordance with the ethical guidelines
for surveillance in populations at higher risk for HIV,
the Lisbon Cohort of MSM offers all participants: timely
results, information about HIV and AIDS, counselling
on HIV prevention and with regard to other health or
social needs, linkage to treatment, and care to the
extent possible with local resources and protocols with
health services for referrals.9
Funding
From April 2011 to March 2014, there was no speciﬁc
funding for this study. All direct costs with human
resources and materials were supported through
CheckpointLX as part of its daily activity. Since April
2014, additional speciﬁc funding has been obtained as
part of the European Commission DG SANCO—Health
and Consumers funded Euro HIV EDAT project (grant
number 20131101). From inception, ISPUP has pro-
vided pro bono contribution through the allocation of
research staff time and information technology support
(programming, software and hardware) to the project.
Recruitment and follow-up of participants
Recruitment is generally made on the ﬁrst visit to
CheckpointLX, where peer counsellors invite all eligible
individuals to enter the cohort. Eligibility criteria for
entering the cohort are being a male aged 18 or over,
regardless of nationality or residence, reporting having
had sex with other men and having a HIV-negative test
result. CheckpointLX is publicised in MSM socialising
sites such as bars, discos, saunas, sex shops and guest-
houses, parties and events of the gay community, cruis-
ing areas and online social networks. The centre itself,
since it is located at a Lesbian Gay Bisexual Transgender
socialising quarter, promotes walk-ins. Promotional mate-
rials include ﬂyers, videos, stickers, banners at online
social networks and prevention kits containing condoms,
lubricant and an information card about CheckpointLX.
Follow-up is intended to take place at intervals of
6 months, although the exact time between visits is
adjusted according to the convenience of the partici-
pant. Men who leave their contact details are invited to
come back for follow-up visits through text messages or
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email from CheckpointLX staff. All the remaining parti-
cipants are interviewed and tested for HIV whenever
they decide to appear again for testing. Repeat visits are
identiﬁed by asking if the individual has already been
invited to enter the cohort. Most participants do not
have trouble remembering if they are part of the cohort.
However, if someone does not remember being enrolled
in the cohort, the peer counsellor usually gives him
some external cues.
End points for follow-up are the acquisition of HIV
infection or death. Recruitment began almost 3 years
ago; since then, we have followed 804 participants for a
total of 893 person-years. Median time between visits was
208 days (approximately 7 months) and 25th–75th cen-
tiles were 148–308 days (approximately 5–10 months).
Study procedures
Questionnaire
At each visit, a face-to-face interview is performed by a
trained CheckpointLX peer counsellor and data are
recorded using a structured questionnaire. The ques-
tionnaire applied at cohort entry is divided into the fol-
lowing sections: sociodemographic characteristics, HIV
testing history, sexual life and partners, condom use, use
of alcohol and drugs, postexposure prophylaxis (PEP)
and other sexually transmitted infections (STIs).
Follow-up questionnaires update time-varying informa-
tion on all sections. The questionnaire is provided as an
online supplementary ﬁle; detailed content is presented
in table 1.
Information is collected from those eligible MSM who
decline to participate but agree to provide some base-
line data, concerning age, gender, country of origin,
educational level, HIV testing history, date and result of
previous HIV test, sexual identity, screening for HIV and
syphilis at the index visit to CheckpointLX, and reasons
for declining participation. Questionnaires are identiﬁed
through a sequential number, and each participant is
identiﬁed with a six-digit and four-letter unique code
corresponding to their date of birth (YYMMDD), and
the ﬁrst two letters of their ﬁrst and last names, which
allows for data linkage during follow-up while protecting
personal identity.9 Periodically, questionnaires are sent
to ISPUP where they are processed into a computer-
based data management system, and where data are
stored and analysed.
Rapid HIV testing
Rapid testing for HIV-1 and HIV-2 is performed at each
visit by the same peer counsellor who conducts the inter-
view. From April 2011 to April 2012, two rapid tests
were used, namely the Retrocheck HIV (QUALPRO
DIAGNOSTICS, Goa, India; manufacturer reported sensi-
tivity=100.00% and speciﬁcity=99.75%) and Hexagon HIV
(Human GmbH, Wiesbaden, Germany; manufacturer
reported sensitivity=100.00% and speciﬁcity=99.50%).
Since then, only the Alere Determine HIV-1/2 (Alere
Medical Co, Ltd, Chiba, Japan; manufacturer reported
sensitivity=100.00% and speciﬁcity=100.0%, although
some studies refer lower speciﬁcity13 14) has been used
according to the instructions provided by the manufac-
turer. In case of a reactive test, an outpatient appointment
is scheduled for every participant that accepts it at the
HIV/Infectious diseases clinic at Santo António dos
Capuchos Hospital in Lisbon, where a conﬁrmatory test is
performed. The peer counsellor offers to accompany the
participant to that appointment. Pretest and post-test
counselling is offered at every visit.
Syphilis rapid testing
Rapid testing for detection of Treponema pallidum anti-
bodies is proposed to every individual who reports with
no prior history of syphilis infection or who is unaware
of a previous infection; in this instance the Alere
Determine Syphilis TP (Alere Medical Co, Ltd, Chiba,
Japan; manufacturer reported sensitivity=92.31% and
speciﬁcity=100.00%) is used according to the instruc-
tions provided by the manufacturer. In the case of a
reactive test, a medical appointment is proposed and
scheduled at CheckpointLX as part of the Checklist STI
clinic, where a conﬁrmatory test is performed and treat-
ment is prescribed, if needed.
Statistical procedures
Characteristics of participants at cohort entry were
described using absolute and relative frequencies in the
case of categorical variables. Medians and percentiles,
25 and 75 (P25-P75), were used to describe continuous
variables. Comparisons between groups were performed
using the χ2 test or Fisher’s exact test when variables
were categorical. For continuous variables the
Mann-Whitney test was used. In data analysis, all possible
answer categories are described, but the missing answers
are excluded from the denominator of proportions for
each item since no information at all was provided. This
is due to the fact that the question was not asked or not
recorded in the questionnaire form. The ‘rather not say’
answers were included in the denominator since they
provide valid information reported by the participants.
Characteristics of enrolled population between April 2011
and February 2014
Between April 2011 and February 2014, there were 3301
potential eligible individuals, 195 (5.9%) of whom had a
HIV reactive test at entry and therefore were not
included in the cohort. The remaining 3106 were eli-
gible to the cohort. Among those, 923 (29.7%) declined
to participate, and 2183 (70.3%) were enrolled in the
cohort. As of February 2014, 804 of the 2183 partici-
pants had been re-evaluated at least once, yielding
approximately 2300 questionnaires (ﬁgure 1). The most
common reasons for declining participation were having
no interest in the study (25.7%), not having the time
(23.5%) and not living in Portugal (18.0%). No add-
itional information was collected on this topic.
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Table 1 Content of the questionnaire
Entry Follow-up
1. Sociodemographic characteristics
Date of birth ✓ –
Gender ✓ –
Country of birth ✓ –
Educational level ✓ ✓
Employment status ✓ –
2. HIV testing
Ever tested for HIV ✓ –
Access to HIV testing result ✓ –
Reasons for not testing or not having HIV test result ✓ –
Number of previous HIV tests ✓ –
Place, date and result of previous HIV test ✓ ✓
Reasons for index test ✓ ✓
3. Sexual life and partners
Sexual identity ✓ ✓
Age at first anal intercourse ✓ –
Role in anal intercourse ✓ ✓
Characteristics of sexual partners in the previous 12 months/since the previous visit* ✓ ✓
A. Steady partner
Steady partner in the previous 12 months/since the previous visit ✓ ✓
Duration of the relationship with steady partner ✓ ✓
Gender of steady partner ✓ ✓
Sexual practices with steady partner ✓ ✓
Sexual intercourse with other partners ✓ ✓
HIV status of the steady partner ✓ ✓
B. Occasional partner
Occasional partner in the previous 12 months/since the previous visit ✓ ✓
Number of occasional partners in the previous 12 months/since the previous visit ✓ ✓
Sexual practices with an occasional partner ✓ ✓
Venues used to meet occasional partners ✓ ✓
C. Sex work
Having sex for money or drugs in the previous 12 months/since previous visit ✓ ✓
4. Condom use
Condom use with a steady partner in the previous 12 months/since the previous visit ✓ ✓
Condom use with a steady partner in the last anal intercourse ✓ ✓
Condom use with an occasional partner in the previous 12 months/since the previous visit ✓ ✓
Condom use with an occasional partner in the last anal intercourse ✓ ✓
Condom use for oral sex ✓ ✓
Reasons for not using condom ✓ ✓
Lubricant use for anal intercourse ✓ ✓
5. Alcohol and drugs
Lifetime use of alcohol or drugs before or during intercourse ✓ –
Frequency of use of alcohol or drugs before or during intercourse in the previous 12 months/since the
previous visit
✓ ✓
Perception of reduction in condom use due to use of alcohol or drugs ✓ ✓
6. Postexposure prophylaxis
Knowledge of PEP ✓ –
Lifetime use of PEP ✓ –
Use of PEP in the previous 12 months/since the previous visit ✓ ✓
7. STIs and hepatitis
Lifetime history of STI (symptoms or diagnosis) ✓ –
Symptoms of STI in the previous 12 months/since the previous visit ✓ ✓
Lifetime history of STI diagnosis ✓ –
Diagnosis of STI in the previous 12 months/since the previous visit ✓ ✓
Immunisation status for hepatitis A and hepatitis B ✓ ✓
Lifetime history of hepatitis virus A, B or C diagnosis ✓ ✓
*Bisexual men; men with different partners; sex workers; HIV-positive men; injecting drug users; women; trios/group sex.
PEP, postexposure prophylaxis; STI, sexually transmitted infection.
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As summarised in table 2, there were signiﬁcant differ-
ences between participants and those who declined to
participate: participants self-identiﬁed more frequently
as homosexual (83.9% vs 78.3%, p<0.001); participants
were more frequently born in Portugal (75.7% vs 59.0%,
p<0.001); and 58.1% of participants had a university
degree compared with 51.4% among those who
declined to participate. The proportion of individuals
Figure 1 Flow chart of
enrolments between April 2011
and February 2014.
Table 2 Comparison of sociodemographic characteristics between participants in the cohort and those who declined to
participate
Participants Declined to participate
p Value2183 (70.3) 923 (29.7)
Sexual identity, n (%) <0.001
Homosexual 1831 (83.9) 709 (78.3)
Bisexual 306 (14.0) 151 (16.7)
Heterosexual 28 (1.3) 37 (4.1)
Other/did not know/rather not say 17 (0.8) 8 (0.9)
Missing 1 18
Age, median (P25-P75) 29 (23–36) 30 (24–38) 0.074
Country/region of origin, n (%) <0.001
Portugal 1573 (75.7) 539 (59.0)
Brazil 231 (11.1) 160 (17.5)
Other European country 139 (6.7) 141 (15.4)
African country 89 (4.3) 27 (3.0)
Other American country 31 (1.5) 30 (3.3)
Asia/Middle East/Oceania 9 (0.4) 16 (1.8)
Rather not say 5 (0.2) 1 (0.1)
Missing 106 9
Educational level, n (%) <0.001
Basic education or less 78 (3.6) 101 (11.3)
Secondary education 564 (25.9) 288 (32.3)
Professional training 260 (11.9) 36 (4.0)
Bachelor 896 (41.0) 341 (38.2)
Master or Doctoral 373 (17.1) 118 (13.2)
Other/rather not say 10 (0.5) 9 (1.0)
Missing 2 30
Previous HIV testing, n (%) 0.167
Yes 1650 (81.9) 766 (83.8)
No 354 (17.6) 145 (15.9)
Did not know 11 (0.5) 2 (0.2)
Rather not say 0 (0.0) 1 (0.1)
Missing 168 9
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who had a previous HIV test was similar between groups
(81.9% in participants vs 83.8% in those who declined
to participate).
Characteristics of cohort participants
Median (P25-P75) number of HIV tests prior to cohort
entry was 3 (2–6) and the most common reasons for the
index HIV test were: to check health status/routine
(81.3%), perception of exposure to HIV more than
3 months before (50.5%) and within the previous
3 months (40.7%; table 3).
Median (P25-P75) age at ﬁrst AI (receptive or inser-
tive) was 18 (16–22) years, and 1409 (65.2%) men
reported having a versatile role on AI, while 553
(25.6%) reported having only an insertive role and 177
(8.2%) only a receptive role. Twelve per cent reported
sexual intercourse with HIV-positive men in the previous
12 months (table 4).
In the previous 12 months, 1373 (63.0%) participants
had at least one steady partner, of whom 108 (7.9%)
had a HIV-positive partner, 338 (24.8%) were unaware
Table 3 Characteristics related with HIV testing
HIV testing N (%) Missing
Previous HIV testing (n=2183) 168
Yes 1650 (81.9)
No 354 (17.6)
Did not know 11 (0.5)
Rather not say 0 (0.0)
Number of previous tests, median
(P25-P75)
3 (2–6) 31
Place of last HIV test (n=1650) 2
Public network of VCT centres
(CAD)
506 (30.7)
Family doctor (National health
service)
311 (18.9)
Public hospital (National health
service)
182 (11.0)
Abroad 152 (9.2)
Private laboratory 150 (9.1)
Private hospital or clinic 144 (8.7)
CheckpointLX 79 (4.8)
Blood donation 45 (2.7)
Mobile unit 28 (1.7)
Other 49 (3.0)
Did not know 2 (0.1)
Reasons for index test (n=2183)*
To check health status/routine 1736 (81.3) 49
Perception of HIV exposure
more than 3 months before
1084 (50.5) 38
Perception of HIV exposure in
the previous 3 months
884 (40.7) 9
Accident with condom use
(rupture/left inside)
183 (8.6) 56
My partner asked me to test for
HIV
158 (7.4) 57
To stop using condom with my
partner
149 (7.0) 64
Partner diagnosed HIV
+/disclosed HIV+ status
138 (6.5) 56
Possible window period by the
time of the last test
136 (6.4) 61
Symptoms/medical indication 58 (2.7) 61
Other reason 159 (7.3) –
*Percentage of participants that answered ‘yes’ at each option
after excluding missing answers. The remaining participants
answered no, did not know or rather not say.
CAD, Centro de Aconselhamento e Deteção Precoce do VIH;
VCT, voluntary counselling and testing.
Table 4 Characteristics related with sexual life and
partners
Sexual life and partners N (%) Missing
Age at first anal intercourse,
median (P25-P75)
18 (16–22) 216
Role on anal intercourse 22
Only insertive 553 (25.6)
Only receptive 177 (8.2)
Versatile 1409 (65.2)
Did not know 2 (0.1)
Rather not say 20 (1.0)
Intercourse with at least one of the following in the
previous 12 months
Bisexual men 31
Yes 732 (34.0)
No 1145 (53.2)
Did not know 262 (12.2)
Rather not say 13 (0.6)
Men with different sex partners 32
Yes 1475 (68.6)
No 491 (22.8)
Did not know 172 (8.0)
Rather not say 13 (0.6)
Sex workers (even if not paid) 32
Yes 133 (6.2)
No 1920 (89.3)
Did not know 85 (4.0)
Rather not say 13 (0.6)
HIV-positive men
Yes 259 (12.0) 32
No 1181 (54.9)
Did not know 698 (32.5)
Rather not say 13 (0.6)
Injecting drug users 32
Yes 16 (0.7)
No 1958 (91.0)
Did not know 164 (7.6)
Rather not say 13 (0.6)
Women 32
Yes 287 (13.3)
No 1851 (86.1)
Did not know 0 (0.0)
Rather not say 13 (0.6)
Trios/group sex 33
Yes 585 (27.2)
No 1549 (72.0)
Did not know 1 (0.0)
Rather not say 15 (0.7)
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of their steady partner’s HIV status and the remaining
913 (67.0%) stated that their steady partner was
HIV-negative. More than half of the men who had at
least one steady partner reported no condom use with
the steady partner in the last sexual encounter (LSE)
and approximately 72.0% reported inconsistent use over
the previous 12 months. Among those in a serodiscor-
dant relationship, 43.7% reported inconsistent use of
condoms and that proportion was 71.0% among those
unaware of their steady partner’s HIV status (table 5).
Sexual intercourse with at least one occasional partner
in the previous 12 months was reported by 1860 (85.2%)
participants and the median (P25-P75) number of part-
ners was 4 (2–10). Twenty-one per cent of men who had
at least one occasional partner reported no condom use
with an occasional partner in the LSE and 46.4%
reported inconsistent use in the previous 12 months. The
most referred venues where participants usually met their
occasional partners were the internet (72.2%), discos
and gay bars (48.4%), and cruising sites (23.2%; table 6).
Condoms were always used for oral sex by 2.3% of par-
ticipants. Always using condoms for AI in lifetime was
reported by 652 (32.9%) participants. Among the 1318
(66.5%) participants who reported not having always
used condoms for AI, the most common reasons for
engaging in unprotected AI were a steady partner
(66.2%), a steady partner after testing negative for HIV
(47.9%), ‘reliable’ persons (39.8%) and being too
aroused (37.1%; table 7).
Lifetime use of alcohol (regardless of the amount) or
drugs before or during intercourse was reported by 1520
(69.7%) participants, and 1262 (59.5%) reported con-
sumption in the previous 12 months. The most frequently
Table 5 Characteristics related with steady partners
Steady partner N (%) Missing
Steady partner in the previous
12 months (n=2183)
2
Yes, one 1254 (57.5)
Yes, more than one 119 (5.5)
No 798 (36.6)
Did not know 0 (0.0)
Rather not say 10 (0.5)
HIV status of steady partner
(n=1373)
11
HIV negative 913 (67.0)
HIV positive 108 (7.9)
Did not know 338 (24.8)
Rather not say 3 (0.2)
Condom use with steady partner
In the last sexual encounter
(n=1373)
70
Yes 572 (43.9)
No 718 (55.1)
Did not know 5 (0.4)
Rather not say 8 (0.6)
Frequency in the previous
12 months (n=1373)
69
Always 364 (27.9)
Often/occasionally/rarely/never 931 (71.4)
Rather not say 9 (0.7)
Frequency in the previous
12 months with HIV-positive
steady partner (n=108)
5
Always 57 (55.3)
Often/occasionally/rarely/never 45 (43.7)
Rather not say 1 (1.0)
Frequency in the previous
12 months with unknown HIV
status steady partner (n=338)
10
Always 95 (29.0)
Often/occasionally/rarely/never 233 (71.0)
Rather not say 0 (0.0)
Table 6 Characteristics related with occasional partners
Occasional partners N (%) Missing
Occasional partners in the
previous 12 months (n=2183)
0
Yes 1860 (85.2)
No 312 (14.3)
Rather not say 11 (0.5)
Number of occasional partners in
the previous 12 months: median
(P25-P75) (n=1860)
4 (2–10) 45
Being paid for sex with money or
drugs in the previous 12 months
(n=1860)
1
Yes 62 (3.3)
No 1796 (96.6)
Did not know 1 (0.1)
Condom use with occasional partner
In the last sexual encounter
(n=1860)
124
Yes 1360 (78.3)
No 367 (21.1)
Did not know 8 (0.5)
Rather not say 1 (0.1)
Frequency in the previous
12 months (n=1860)
123
Always 925 (53.3)
Often/occasionally/rarely/never 806 (46.4)
Did not know 2 (0.1)
Rather not say 4 (0.2)
Venues used to meet occasional partners (n=1860)*
Internet 1338 (72.2) 8
Discos and gay bars 897 (48.4) 7
Cruising sites 430 (23.2) 10
Saunas 356 (19.3) 11
Gym 232 (12.6) 14
‘Dark rooms’ (including sex
shops)
129 (7.0) 11
Sex clubs 92 (5.0) 10
Other 445 (23.9) –
*Percentage of participants that answered ‘yes’ at each option
after excluding missing answers. The remaining participants
answered no, did not know or rather not say.
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reported psychoactive substances were alcohol (57.6%),
poppers (17.8%) and cannabis (15.9%; table 8).
A little over one-third of participants had heard about
PEP, and 54 participants (2.7%) knew about and had
used PEP (table 9).
A lifetime history of STI symptoms or diagnoses was
reported by 37.1% of respondents; and 9.9% reported
STI symptoms/diagnoses in the past 12 months. The
most commonly reported STI in the past 12 months was
gonorrhoea (2.5%), followed by syphilis (1.7%). In total,
0.5% of respondents reported a lifetime history of hepa-
titis C diagnosis (none of whom reported injection drug
use; table 10).
STRENGTHS AND LIMITATIONS
The Lisbon Cohort of MSM is the ﬁrst Portuguese pro-
spective study of MSM in the context of HIV incidence
and testing. As an open prospective study, it will provide
information on the trends of HIV infection and other
STIs among MSM in Portugal, and it will contribute to
identify and monitor determinants of infection, includ-
ing risk-taking behaviours.
Until recently, serological and behavioural evidence
relating to HIV among MSM in Portugal was scarce,
apart from the necessarily succinct indicators obtained
through routine national HIV surveillance. Two recent
cross-sectional studies15 16 targeting MSM in Portugal
provided the ﬁrst population-based estimates of self-
reported prevalence among MSM with a previous HIV
test: 10.9%6 and 10.3% (Gama A, 2013, personal com-
munication). In addition to these alarming estimates,
both studies have raised important concerns regarding
the future of the epidemic in Portugal supporting the
need for closer monitoring of behavioural and sero-
logical indicators within a dynamic framework.
A few cohorts follow HIV-negative MSM internationally
with different recruitment strategies and settings. For
instance, the Amsterdam Cohort Studies (ACS) on HIV
infection and AIDS, which started shortly after the ﬁrst
cases of AIDS had been diagnosed in the Netherlands,17
and the Multicenter AIDS Cohort Study (MACS),
initiated in 1983 in four universities in the USA;18 both
are based at formal health or academic facilities. The
Omega Cohort Study in Montreal, Canada, was carried
out from October 1996 to July 2003 at formal health
facilities and at community organisations.19 The Health
in Men (HIM) in Sydney, Australia, was established in
July 200120 and, recently, in 2008, The ITACA cohort–
HIV negative MSM cohort study for early diagnosis of
HIV and other STIs and their determinants was estab-
lished in Barcelona. Both of these are community-based
open cohorts.21 These cohorts have signiﬁcantly contrib-
uted to our understanding of the HIV/AIDS epidemic,
Table 7 Characteristics related with condom use
Condoms N (%) Missing
Lifetime condom use on oral sex (n=2183) 7
Always 49 (2.3)
Often/occasionally/rarely/never 2106 (96.8)
Rather not say 21 (1.0)
Lifetime condom use on anal intercourse (n=2183) 202
Always 652 (32.9)
Often/occasionally/rarely/never 1318 (66.5)
Rather not say 11 (0.6)
Reasons for not using condom on anal intercourse (n=1318)*
With steady partner 870 (66.2) 3
With steady partner after testing for HIV and both were negative 629 (47.9) 5
With a ‘reliable’ person 523 (39.8) 3
Being too aroused 487 (37.1) 6
Condom reduces pleasure 360 (27.4) 5
With a partner who declares he is HIV negative 303 (23.1) 7
Not having condoms at that moment 261 (19.9) 5
If the participant has used alcohol or drugs 226 (17.2) 5
Condom interrupts sexual intercourse 201 (15.3) 5
Does not like using condoms 205 (15.6) 5
Condom makes the participant lose erection 188 (14.3) 4
With a partner who does not want to use 124 (9.4) 5
Being in a sex venue without condoms available 59 (4.5) 6
Condoms are expensive 40 (3.0) 6
With a partner who declares undetectable viral load† 19 (9.5) 5
Allergy to latex 24 (1.8) 6
Other reasons 77 (5.8) –
*Percentage of participants that answered ‘yes’ at each option after excluding missing answers. The remaining participants answered no, did
not know or rather not say.
†Among men who have sex with men who reported sexual intercourse with HIV-positive men in the previous 12 months.
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and the HIM and ITACA cohorts, especially, will enable
comparisons of their ﬁndings with those of our newly
developed infrastructure. Additionally, the Lisbon
Cohort of MSM has the potential to serve as a modern
decentralised surveillance structure that will provide
dynamic information about the frequency of the disease
and its determinants in this group. Within our geo-
graphical setting, this study has the potential to enable
locally adapted responses in terms of service provision,
namely on the development of effective strategies to
anticipate diagnosis. The cohort will also allow for com-
parisons of behavioural indicators drawn from entry and
follow-up questionnaires within the international
context, since it collects the set of indicators for behav-
ioural surveillance among MSM deﬁned by the
European Centre for Disease Control and Prevention
(ECDC).22 Finally, a set of speciﬁc analytical research
objectives will be pursued, with strong emphasis on how
contextual and behavioural trajectories throughout
follow-up may be used to predict the risk of
seroconversion.
The Lisbon Cohort of MSM has a relevant strength in
the peer-based approach provided by CheckpointLX.
Peer-based services attempt to promote an adequate
response to MSM needs, to be non-judgemental and
inclusive, which has been reported as the preference of
gay and other MSM for testing services.23 From a
research point of view, we believe this approach can also
help in reducing social desirability bias with regard to
the information collected, and can be more cost-
effective than interventions based on clinical staff.24
Another strength of the cohort is the assurance of ano-
nymity, which is expected to inﬂuence completeness of
reporting and disclosure of risk.9 Furthermore,
CheckpointLX peer counsellors accompany newly iden-
tiﬁed HIV-positive participants to their ﬁrst appointment
at a HIV/Infectious disease clinic to boost linkage to
care. This strategy is in common with that of other
community-based centres dedicated to MSM in
European countries that have shown to have high efﬁ-
ciency in HIV detection and linkage to care.25 26
The Lisbon Cohort of MSM, as a facility-based struc-
ture, is unlikely to result in a representative sample of
the source MSM population, which limits the generalis-
ability of our ﬁndings to the whole community. This is a
frequent concern in studies with non-probabilistic
samples, but it should not be used as an argument for
not attempting to generate the best scientiﬁc evidence
possible within real-world constraints. In addition, by fol-
lowing only MSM who actively seek HIV testing, we are
arguably selecting a subgroup that might be on average
at a higher risk of infection than the general MSM com-
munity. Consequently, this focuses our attention onto a
priority subset of the population (even if potentially
more aware than those not reached by the service). The
following comparisons are useful to assess the extent of
selection bias (table 11). In the 2007 National Health
and Sexuality Survey (HSS),27 which included a repre-
sentative sample of the Portuguese population, 4.7% of
adult male individuals reported some kind of sexual
contact with other men in their lifetime, 3.0% of sexu-
ally active men had sex with men in the previous
12 months, and 0.9% reported homosexual identity.
Despite the heteronormative frame still persistent in
Portuguese society,27 the proportion of men reporting
sex with other men is quite similar to that estimated by
Marcus et al, where approximately 3.0% of the adult
male population living in Portugal were estimated to be
MSM.28 Men in our sample are clearly younger than in
the HSS, where about 31% were less than 25 years old,
whereas men who have had some kind of sexual contact
Table 9 Characteristics related with PEP
PEP (n=2183) N (%) Missing
Did not know about PEP 1228 (61.2) 175
Knows but never used 726 (36.2)
Knows and used 54 (2.7)
PEP, postexposure prophylaxis.
Table 8 Characteristics related with alcohol and drug use
before or during intercourse
Alcohol and drugs N (%) Missing
Lifetime use of alcohol or drugs
before or during intercourse
(n=2183)
1
Yes 1520 (69.7)
No 662 (30.3)
Use of alcohol or drugs before or
during intercourse in the previous
12 months (n=2183)
62
Yes 1262 (59.5)
No 837 (39.4)
Did not know 4 (0.2)
Rather not say 19 (0.9)
Ever used alcohol or drugs before or during intercourse in
the previous 12 months (n=2183)*
Alcohol 1256 (57.6) 4
Poppers 389 (17.8) 2
Cannabis 329 (15.9) 114
Cocaine 236 (10.8) 1
Ecstasy 123 (5.6) 3
Viagra/cialis/similar 89 (4.1) 2
Mephedrone 76 (3.5) 3
Amphetamines 72 (3.3) 3
GHB 37 (1.7) 2
Ketamine 32 (1.5) 2
LSD 31 (1.4) 3
Heroin 7 (0.3) 3
Methadone 8 (0.4) 2
Others 49 (2.2) –
*Percentage of participants that answered ‘yes’ at each option
after excluding missing answers. The remaining participants
answered no, did not know or rather not say.
GHB, gamma-hydroxybutyric acid; LSD, lysergic acid
diethylamide.
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Table 10 Characteristics related with STIs
STIs and hepatitis N (%) Missing
Lifetime history of STI (symptoms or diagnosis) (n=2183) 6
Yes, in the previous 12 months 216 (9.9)
Yes, more than 12 months before 593 (27.2)
No 1368 (62.8)
STI diagnosed (n=2183)
History of gonorrhoea 3
Yes, in the previous 12 months 57 (2.5)
Yes, more than 12 months before 169 (7.8)
No 1946 (89.3)
Did not know 8 (0.4)
History of syphilis 1
Yes, in the previous 12 months 38 (1.7)
Yes, more than 12 months before 116 (5.3)
No 2026 (92.9)
Did not know 2 (0.1)
History of condyloma or genital warts 3
Yes, in the previous 12 months 68 (3.1)
Yes, more than 12 months before 22 (1.0)
No 2088 (95.6)
Did not know 2 (0.1)
History of chlamydia 2
Yes, in the previous 12 months 64 (2.9)
Yes, more than 12 months before 14 (0.6)
No 2096 (96.1)
Did not know 7 (0.3)
History of genital herpes 3
Yes, in the previous 12 months 4 (0.2)
Yes, more than 12 months before 21 (1.0)
No 2153 (98.8)
Did not know 2 (0.1)
History of Trichomonas 1
Yes, in the previous 12 months 3 (0.1)
Yes, more than 12 months before 1 (0.0)
No 2176 (99.7)
Did not know 2 (0.1)
History of lymphogranuloma venereum 1
Yes, in the previous 12 months 0 (0.0)
Yes, more than 12 months before 2 (0.1)
No 2178 (99.8)
Did not know 2 (0.1)
Lifetime history of hepatitis diagnosis (n=2183) 12
History of hepatitis A
Yes 127 (5.8)
No 1897 (87.4)
Did not know 137 (6.3)
Rather not say 10 (0.5)
History of hepatitis B 13
Yes 52 (2.4)
No 2002 (92.3)
Did not know 106 (4.9)
Rather not say 10 (0.5)
History of hepatitis C 15
Yes 10 (0.5)
No 2032 (93.7)
Did not know 116 (5.4)
Rather not say 10 (0.5)
Vaccination (n=2183) 8
Hepatitis A
Yes 827 (38.0)
No 742 (34.1)
Did not know 596 (27.4)
Rather not say 10 (0.5)
Hepatitis B 6
Yes 1603 (73.6)
No 312 (14.3)
Did not know 252 (11.6)
Rather not say 10 (0.5)
STI, sexually transmitted infection.
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with men in that age strata represent only 9.8% in the
HSS. Men in the Lisbon Cohort reported more fre-
quently of having had a previous HIV test (81.9% vs
61.0% in HSS). When compared with the European
MSM internet survey results15 from a subanalysis includ-
ing only participants aged 18 or more living in the
Lisbon region, men in our sample have lower median
age (29 vs 32) and lower educational level (58.1% with
an university degree vs 61.9%), but report homosexual
identity more frequently (83.9% vs 73.6%), previous
HIV test (81.9% vs 77.0%) and lifetime use of PEP
(2.7% vs 2.1%).
We may assume that we are capturing men who are
more self-identiﬁed as homosexual, which was expected
once CheckpointLX was targeted to this group, and
perhaps more aware of HIV risk as the frequency of
uptake of HIV testing is higher than in the previous
studies. It is important to stress that since CheckpointLX
promotion strategies remained similar during follow-up,
we do not expect a change in the extent of selection
bias over time, which is particularly important for the
estimation of secular trends of infection and behaviours
in the source population.8–10
Participation bias is also a key methodological issue in
epidemiological studies. In fact, participants in our study
are more self-identiﬁed as homosexual, more frequently
born in Portugal and more educated than those who
declined to participate. This implies that important data
may be missing on a harder to reach subset of the target
population. However, it is interesting to note that the
proportion of a previous HIV test is similar between
groups, suggesting that both groups may have similar
perceived high risk of acquiring HIV.29 30
Attrition is a main concern in prospective investiga-
tions; due to the fact that this is not an interval cohort
with ﬁxed follow-up times, the ability to estimate attri-
tion in a short time frame is limited. However, efforts
have been made in order to minimise dropout rates.
CheckpointLX peer counsellors ask all participants to
provide their email or mobile phone contact details on
their ﬁrst visit and to update their contact details in the
follow-up assessments. These details are then used, with
the consent of the participants, in order to send remin-
ders within the month of an intended follow-up.
One other ongoing challenge is the possible behav-
ioural modiﬁcation by cohort participants due to their
participation in an investigation, known as the
Hawthorne effect. This aspect also relates to the dual
role of CheckpointLX as a healthcare/counselling pro-
vider and research structure. Checkpoint’s ﬁrst priority
is that appropriate and high-quality pretest and post-test
information or counselling is offered, and hopefully that
will produce a change towards better health empower-
ment, likely to inﬂuence the risk of the outcomes being
studied.31
COLLABORATION
We invite scientists, researchers and students from gradu-
ation or postgraduation to get involved in data collection
and/or analyses, and to raise new scientiﬁc questions in
the scope of the Lisbon Cohort of MSM. Requests for
data analysis, presentation or publication, must be sub-
mitted to the Lisbon Cohort of MSM scientiﬁc coordin-
ation, and will require acknowledgement that Lisbon
Cohort of MSM has the property of the data. Information
is available at http://www.checkpointLX.com.
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